1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Stentys
  6. News
  7. Press Releases
    STNT   FR0010949404

STENTYS

(STNT)
End-of-day quote Euronext Paris  -  2019-07-21
0.4600 EUR   -2.95%
2020Stentys S.A. Reports Earnings Results for the Half Year Ended June 30, 2020
CI
2020STENTYS : Financial Information for the First Quarter Of 2020
BU
2020STENTYS S.A. Announces Revenue Results for the First Quarter Of 2020
CI
SummaryQuotesChartsNewsCompany 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société STENTYS
2020STENTYS : Financial Information for the First Quarter Of 2020
BU
2020STENTYS : Financial Information for the First Quarter of 2020
PU
2020STENTYS : 2019 Annual Results
PU
2019STENTYS : Convening of another Combined General Meeting on November 14, 2019
PU
2019STENTYS : 2019 half-year results
PU
2019STENTYS : Financial Information for the Third Quarter of 2019
PU
2019STENTYS : Financial Information for the First Half of 2019
PU
2019STENTYS : Convening of another Combined General Meeting on June 25, 2019
PU
2019STENTYS : Financial Information for the First Quarter of 2019
PU
2019STENTYS : 2018 Annual results
PU
20192018 REVENUES : exceeding €10 million on a pro forma basis
PU
2018STENTYS : Financial Information for the Third Quarter of 2018
PU
2018STENTYS : 2018 half-year results
PU
2018STENTYS : Report on the General Meeting of June 4, 2018
PU
2018STENTYS : Convening of another Combined General Meeting on June 4, 2018
PU
2018STENTYS : announces plans to acquire MINVASYS
PU
201712 OCTOBER 2017 : Revenues for the Third Quarter of 2017
PU
201702 OCTOBER 2017 : 2017 half-year results
PU
201727 JULY 2017 : STENTYS Completes Enrollment of the TRUNC Study
PU
201712 JULY 2017 : Revenues of €1.7 million in the second quarter of 2017
PU
201722 JUNE 2017 : Report on the Combined Shareholders' Meeting of June 22, 2017
PU
201724 MAY 2017 : Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3..
PU
201703 APRIL 2017 : STENTYS is strengthening its Board by co-opting two new independent member..
PU
201712 JANUARY 2017 : 2016 Annual Revenues up 20% at €7.3 Million
PU
201612 OCTOBER 2016 : STENTYS Reports 26% Year-over-Year Growth in Nine-Month 2016 Revenues
PU
201615 SEPTEMBER 2016 : 2016 First-Half Results
PU
201612 JULY 2016 : STENTYS: 41% Increase in Revenues in the Second Quarter of 2016
PU
201604 JULY 2016 : STENTYS: Appointment of Cardiovascular Device Veteran as New CEO
PU
201604 JULY 2016 : STENTYS: Appointment of Cardiolovascular Device Veteran as New CEO
PU
201608 JUNE 2016 : STENTYS Announces CE Marking of its longest Xposition stent
PU
201612 MAY 2016 : Convening of another Annual General Meeting on June 16, 2016
PU
2016STENTYS : Announces the CE Marking of the Self-Apposing Stent for Left Main Coronary Arter..
PU
2016STENTYS : Reports 2015 Annual Results (16 March 2016)
PU
2016STENTYS : 28 February 2016: Results of Self-Apposing Sirolimus-Eluting Stent Trial Publish..
PU
2016STENTYS : 29 February 2016: Results of Self-Apposing Sirolimus-Eluting Stent Trial Publish..
PU
2016STENTYS : 08 February 2016: Launch of the Commercialization of the first Self-Expanding Dr..
PU
2016STENTYS : 28 January 2016: First Intervention with the Self-Apposing Drug-Eluting Stent fo..
PU
2016STENTYS : Reports 81% Year-over-Year Growth in Fourth-Quarter 2015 Revenues (13 January 20..
PU
2015STENTYS : 22 December 2015: 2016 Financial Agenda
PU
2015STENTYS : 09 December 2015: Enrollment Completion of MiStent Randomized Trial against Xien..
PU
2015STENTYS : Reports 84% Growth in Third-Quarter 2015 Revenues (15 October 2015)
PU
2015STENTYS : Sirolimus-Eluting Stent Confirms Best-in-Class Performance at 3 Years (12 Octobe..
PU
2015STENTYS : Receives CE Mark for Self-Apposing Stent in Lower Limb Artery Disease (28 Septem..
PU
2015STENTYS : 17 September 2015: First Half 2015 Financial Results
PU
2015STENTYS : Reports 40% Increase in Revenues in Q2 2015 (08 July 2015)
PU
2015STENTYS : 16 June 2015: Report on the Combined Shareholders' Meeting of June 15, 2015
PU
2015STENTYS : 19 May 2015: First Clinical Experience with Xposition shows 100% implantation su..
PU
2015STENTYS : 05 May 2015: Convening of another combined Shareholders' Meeting on June 15, 201..
PU
2015STENTYS : rsquo; Next-Generation of Self-Apposing Stent System Receives CE Marking Ahead o..
PU
2015STENTYS : Reports First Quarter 2015 Revenues Rose 28% (16 April 2015)
PU
2015STENTYS : 31 March 2015: 2014 Annual Results
PU
2015STENTYS : 23 February 2015: Results of largest STENTYS Stent Trial in Myocardial Infarctio..
PU
2015STENTYS : 12 February 2015: New Self-Apposing Stent Study in Left Main Coronary Artery
PU
2015STENTYS : Expands Benefits of First Drug-Eluting, Self-Expanding Stent to Lower Limb Arter..
PU
2015STENTYS : 2014 Annual Revenues up 13% to €3.9 Million (22 January 2015)
PU
2015STENTYS : 22 January 2015: 2014 Annual Revenues up 13pc to €3.9 Million
PU
2014STENTYS : Expands Product Offering by Distributing MiStent Drug-Eluting Stent (03 November..
PU
2014STENTYS' : Sirolimus-Eluting Stent Receives CE Marking (27 October 2014)
PU
2014STENTYS : Adds Branch Office in Dubai (25 September 2014)
PU
2014STENTYS : Adds Branch Office in Dubai
PU
2014STENTYS STENT CONTINUES TO SHOW LOW : STENTYS Stent continues to show low mortality two y..
PU
2014STENTYS : Reaches 10,000 Self-Apposing Stent implantations (03 September 2014)
PU
2014STENTYS : to Report First-Half Results on September 22, 2014 (25 August 2014)
PU
2014STENTYS : Reallocates Resources to focus on its Advanced Drug-Eluting Stent Program (31 Ju..
PU
2014STENTYS : First Half 2014 Revenues Rise 18pc (24 July 2014)
PU
2014STENTYS : Expands Marketing of the Self-Apposing Stent in South America (09 July 2014)
PU
2014STENTYS : Completes the Acquisition of Cappella Peel Away Inc. (12 June 2014)
PU
2014STENTYS : to Acquire Stent Delivery Technology for Its Next-Generation of Self-Apposing St..
PU
2014STENTYS : Self-Apposing Stent Featured Prominently at 2014 EuroPCR Conference (27 May 2014..
PU
2014STENTYS : Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Pat..
PU
2014STENTYS : Secures a Standby Equity Facility (14 May 2014)
PU
2014STENTYS : 07 May 2014: Journal of the American College of Cardiology Publication Shows Mal..
PU
2014STENTYS : rsquo; Self-Apposing Stent Featured in New Article Published by the Journal of t..
PU
2014STENTYS : First Quarter Revenues Up 18% from 2013 (24 April 2014)
PU
2014STENTYS : Appoints Medical Device Executive to its Board of Directors (10 April 2014)
PU
1  2  3Next